Assessment of the Airway Smooth Muscle Relaxant Effect of Drotaverine.
| Autor: | Patai Z; LabMagister Training and Science Ltd., Budapest, Hungary.; Horvath Csaba Laboratory of Bioseparation Sciences, MMKK, University of Debrecen, Debrecen, Hungary., Guttman A; Horvath Csaba Laboratory of Bioseparation Sciences, MMKK, University of Debrecen, Debrecen, Hungary.; MTA-PA Translational Glycomics Research Group, MUKKI, University of Pannonia, Veszprém, Hungary., Mikus EG; LabMagister Training and Science Ltd., Budapest, Hungary. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Pharmacology [Pharmacology] 2018; Vol. 101 (3-4), pp. 163-169. Date of Electronic Publication: 2018 Jan 04. |
| DOI: | 10.1159/000485921 |
| Abstrakt: | Background: Drotaverine, a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor, blocks the degradation of 3',5'-cyclic adenosine monophosphate. However, published receptor binding data showed that drotaverin also binds to the L-type voltage-operated calcium channel (L-VOCC). Based on these molecular mechanisms of action, a direct and indirect (by blocking the constrictor response) relaxant effect on airway smooth muscle can be predicted, which has not yet been assessed. Summary: Accordingly, drotaverine and reference agents were tested both on the histamine-, methacholine-, or KCl-induced contraction response and on precontracted guinea pig tracheal preparations. It was found that drotaverine not only relaxed the precontracted tracheal preparations but also decreased mediator-induced contraction. These effects of drotaverine were concentration dependent, with a significantly higher potency on the KCl-induced response, than on either the histamine or methacholine induced one. A similar result was noted for nifedipine. The PDE inhibitor, theophylline, also relaxed the precontracted preparations but was ineffective on the mediator-induced contraction in a physiologically relevant concentration range. Moreover, theophylline did not show selectivity and was the least potent relaxant among the 3 tested molecules. Key Message: These results show that drotaverine is a more potent airway smooth muscle relaxant molecule than theophylline. This enhanced potency on relaxation and inhibition of the constrictor response, at least partly, may be explained by the combined L-VOCC blocking and PDE inhibitory potential of drotaverine. (© 2018 S. Karger AG, Basel.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|